# CeriBell, Inc. Common Stock (CBLL)

> CeriBell, Inc. Common Stock (CBLL) trades at $26.12 (-0.89%) as of 10:48:23 AM EST on Nov 13, 2026, -5.54% over the past month. Market cap is $1.02B, with 3.5 days to cover in short interest.

Canonical: https://massive.com/quote/cbll
Data as of: 2026-11-13T15:48:23.894Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$26.12** -0.23 (-0.89%)
As of 10:48:23 AM EST on Nov 13, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How CeriBell, Inc. Common Stock (CBLL) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -0.91% |
| 1W | -1.81% |
| 1M | -5.54% |
| YTD | +19.06% |
| 1Y | +102.40% |
| 52-wk range | $12.40 – $28.89 |

From daily closes through Nov 13, 2026.

## Key statistics

Today's trading snapshot for CBLL: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $25.86 – $26.42 |
| Open | $26.20 |
| Prev close | $26.35 |
| Volume | 62.57K |
| Market cap | $1.02B |
| Shares out | 38.84M |

## Valuation and profitability ratios

Valuation and profitability ratios for CeriBell, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 9.41 |
| P/B | 8.71 |
| P/FCF | — |
| ROE | -62.9% |
| ROA | -47.3% |
| Debt/Equity | 0.17 |
| Div yield | 0.00% |

As of Nov 12, 2026

## Insider trading

[CeriBell, Inc. Common Stock (CBLL) insider trading](https://massive.com/quote/cbll/insider-trading.md): open-market Form 4 buys and sells by CeriBell, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events CeriBell, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 3, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 3, 2026, CeriBell, Inc. issued a press release announcing its financial results for the fiscal quarter ended September 30, 2026.”
- Jul 30, 2026 · Director appointment
  “Immediately following the foregoing rebalancing, and effective July 28, 2026, the Board increased the authorized size of the Board from seven to nine directors and elected Sharon L. O'Keefe and Thomas A. West to fill the newly created directorships, each to serve as a Class I director until his or her successor is duly elected and qualified, or until his or her earlier resignation or removal. Ms. O'Keefe has also been appointed to the Compensation Committee of the Board, and Mr. West has also been appointed to the Audit Committee of the Board.”
- Jan 5, 2026 · [Regulatory decision](https://massive.com/quote/sec-filings/8-k/regulatory-decisions.md)
  “On January 5, 2026, CeriBell, Inc. (Ceribell) issued a press release announcing that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for Ceribell's Large Vessel Occlusion (LVO) stroke detection and monitoring solution.”
- Jan 2, 2026 · Director departure
  “On December 30, 2025, Lucian Iancovici notified the Board of Directors (the "Board") of CeriBell, Inc. (the "Company") of his resignation from the Board and from his positions as Chair of the Nominating and Corporate Governance Committee and as a member of the Compensation Committee, effective as of December 31, 2025.”
- Dec 12, 2025 · Lease agreement
  “On December 11, 2025, the Company and WTA Pastoria II LLC (the "360 Lessor") entered into the First Amendment, effective December 8, 2025 (the "360 Amendment"), to the Lease dated July 13, 2021... Pursuant to the 360 Amendment, the Company and the 360 Lessor agreed to extend the term of the 360 Lease through January 31, 2028, with a monthly rent of $74,147.00.”

## CBLL short interest

How heavily CBLL is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 3.5 |
| Short interest | 1.96M |
| Avg volume | 550.61K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## CBLL news

The latest news and headlines about CeriBell, Inc. Common Stock (CBLL).

- [CeriBell, Inc. (CBLL) Reports Q3 Loss, Tops Revenue Estimates](https://www.zacks.com/stock/news/3022397/ceribell-inc-cbll-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3022397) · Zacks Investment Research · Nov 3, 2026 · neutral sentiment
- [Compared to Estimates, CeriBell, Inc. (CBLL) Q3 Earnings: A Look at Key Metrics](https://www.zacks.com/stock/news/3022319/compared-to-estimates-ceribell-inc-cbll-q3-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-3022319) · Zacks Investment Research · Nov 3, 2026 · positive sentiment
- [Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe](https://www.globenewswire.com/news-release/2026/07/29/3335078/0/en/Ceribell-Expands-Board-of-Directors-with-Appointments-of-Thomas-West-and-Sharon-O-Keefe.html) · GlobeNewswire Inc. · Jul 29, 2026 · positive sentiment
- [Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates](https://www.globenewswire.com/news-release/2025/11/24/3193418/0/en/Ceribell-Receives-FDA-510-k-Clearance-for-Use-of-Clarity-Algorithm-for-Neonates.html) · GlobeNewswire Inc. · Nov 24, 2025 · positive sentiment
- [Medtech Leader Erica Rogers Joins Ceribell Board of Directors](https://www.globenewswire.com/news-release/2025/09/22/3153859/0/en/Medtech-Leader-Erica-Rogers-Joins-Ceribell-Board-of-Directors.html) · GlobeNewswire Inc. · Sep 22, 2025 · positive sentiment

## About CeriBell, Inc. Common Stock

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 300 |
| Listed | Oct 11, 2024 |

[Company website](https://www.ceribell.com)

## FAQ

### What is the CeriBell, Inc. Common Stock (CBLL) stock price today?

CeriBell, Inc. Common Stock (CBLL) is trading at $26.12 (-0.89% on the day) as of 10:48:23 AM EST on Nov 13, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is CeriBell, Inc. Common Stock?

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the…

### What is the short interest in CBLL?

As of Oct 30, 2026, CBLL has 1.96M shares short and 3.5 days to cover.

### What exchange is CBLL listed on?

CeriBell, Inc. Common Stock (CBLL) trades on Nasdaq in USD, in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry.

## Live data

Prices here are 15-minute delayed. For real-time CBLL quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=CBLL`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [CeriBell, Inc. Common Stock (CBLL) insider trading](https://massive.com/quote/cbll/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms